Effect of SH2B1 on glucose metabolism during pressure overload-induced cardiac hypertrophy and cardiac dysfunction.

Liu, Beilei; Liu, Xuguang; Hu, Shan; Mao, Shuai; Yang, Manqi; Wu, Bin; Wu, Gang

Liu, Beilei; Liu, Xuguang; Hu, Shan; Mao, Shuai; Yang, Manqi; Wu, Bin; Wu, Gang.

Afiliação

Liu B; Department of Cardiology, Hubei Provincial Hospital of Traditional Chinese Medicine, Wuhan, China.
Liu X; Affiliated Hospital of Hubei University of Chinese Medicine, Wuhan, China.
Hu S; Hubei Province Academy of Traditional Chinese Medicine, Wuhan, China.
Mao S; Department of Cardiology, Hubei Provincial Hospital of Traditional Chinese Medicine, Wuhan, China.
Yang M; Affiliated Hospital of Hubei University of Chinese Medicine, Wuhan, China.
Wu B; Hubei Province Academy of Traditional Chinese Medicine, Wuhan, China.
Wu G; Department of Cardiology, Hubei Key Laboratory of Cardiology, Renmin Hospital of Wuhan University, Cardiovascular Research Institute, Wuhan University, Wuhan, China.

Clin Exp Pharmacol Physiol ; 50(10): 815-825, 2023 10.

Article em En | MEDLINE | ID: mdl-37401170

Assuntos

Fosfatidilinositol 3-Quinases; Proteínas Proto-Oncogênicas c-akt; Humanos; Proteínas Proto-Oncogênicas c-akt/metabolismo; Fosfatidilinositol 3-Quinases/metabolismo; Cardiomegalia/metabolismo; Miocárdio/metabolismo; Glucose/metabolismo; RNA Interferente Pequeno/genética; Ácidos Graxos/metabolismo; Miócitos Cardíacos/metabolismo; Proteínas Adaptadoras de Transdução de Sinal/metabolismo

Palavras-chave

PI3K/AKT; SH2B1; cardiac hypertrophy; glucose metabolism

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Fosfatidilinositol 3-Quinases / Proteínas Proto-Oncogênicas c-akt Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google